Search Results

There are 6965 results for: content related to: Age-specific prognosis following spontaneous hepatitis B e antigen seroconversion in chronic hepatitis B

  1. You have free access to this content
    Distinct evolution and predictive value of hepatitis B virus precore and basal core promoter mutations in interferon-induced hepatitis B e antigen seroconversion

    Hepatology

    Volume 57, Issue 3, March 2013, Pages: 934–943, Hung-Chih Yang, Chi-Ling Chen, Yueh-Chi Shen, Cheng-Yuan Peng, Chun-Jen Liu, Tai-Chung Tseng, Tung-Hung Su, Wan-Long Chuang, Ming-Lung Yu, Chia-Yen Dai, Chen-Hua Liu, Pei-Jer Chen, Ding-Shinn Chen and Jia-Horng Kao

    Version of Record online : 7 FEB 2013, DOI: 10.1002/hep.26121

  2. You have free access to this content
    A large case-control study on the predictability of hepatitis B surface antigen levels three years before hepatitis B surface antigen seroclearance

    Hepatology

    Volume 56, Issue 3, September 2012, Pages: 812–819, Wai-Kay Seto, Danny Ka-Ho Wong, James Fung, Ivan Fan-Ngai Hung, Daniel Yee-Tak Fong, John Chi-Hang Yuen, Teresa Tong, Ching-Lung Lai and Man-Fung Yuen

    Version of Record online : 10 JUL 2012, DOI: 10.1002/hep.25718

  3. You have free access to this content
    AASLD Abstracts

    Hepatology

    Volume 56, Issue S1, October 2012, Pages: 191A–1144A,

    Version of Record online : 1 OCT 2012, DOI: 10.1002/hep.26040

  4. Hepatitis B surface antigen levels after hepatitis B e-antigen seroclearance: a longitudinal follow-up study

    Liver International

    Volume 35, Issue 3, March 2015, Pages: 854–859, James Fung, Wai-kay Seto, Danny Ka-ho Wong, Ching-lung Lai and Man-fung Yuen

    Version of Record online : 4 JUN 2014, DOI: 10.1111/liv.12596

  5. You have free access to this content
    Metabolic syndrome delays HBeAg seroclearance in Chinese patients with hepatitis B

    Alimentary Pharmacology & Therapeutics

    Volume 40, Issue 6, September 2014, Pages: 716–726, J. C. Hsiang, G. L.-H. Wong, H. L.-Y. Chan, A. W.-H. Chan, A. M.-L. Chim and V. W.-S. Wong

    Version of Record online : 13 JUL 2014, DOI: 10.1111/apt.12874

  6. You have free access to this content
    HBsAg seroclearance in chronic hepatitis B in the Chinese: Virological, histological, and clinical aspects

    Hepatology

    Volume 39, Issue 6, June 2004, Pages: 1694–1701, Man-Fung Yuen, Danny Ka-Ho Wong, Erwin Sablon, Eric Tse, Irene Oi-Lin Ng, He-Jun Yuan, Chung-Wah Siu, Tamara J. Sander, Eric J. Bourne, Jeff G. Hall, Lynn D. Condreay and Ching-Lung Lai

    Version of Record online : 27 MAY 2004, DOI: 10.1002/hep.20240

  7. You have free access to this content
    Poster Session 3: Hepatitis B: Epidemiology and Natural History History

    Hepatology

    Volume 62, Issue S1, October 2015, Pages: 961A–1001A,

    Version of Record online : 7 OCT 2015, DOI: 10.1002/hep.28233

  8. You have full text access to this OnlineOpen article
    HBsAg spontaneous seroclearance in a cohort of HBeAg-seronegative patients with chronic hepatitis B virus infection

    Journal of Medical Virology

    Volume 88, Issue 1, January 2016, Pages: 79–85, Zhen-Ge Han, Zhong-Hong Qie and Wei-Zhen Qiao

    Version of Record online : 29 OCT 2015, DOI: 10.1002/jmv.24311

  9. You have free access to this content
    Poster Session 4: HBV: Diagnostics, Epidemiology, Prevention, Natural History

    Hepatology

    Volume 60, Issue S1, October 2014, Pages: 1605–1695,

    Version of Record online : 1 OCT 2014, DOI: 10.1002/hep.27528

  10. Risk of hepatocellular carcinoma in cirrhotic hepatitis B virus patients during nucleoside/nucleotide analog therapy

    Hepatology Research

    Volume 45, Issue 8, August 2015, Pages: 872–879, Etsuro Orito, Chitomi Hasebe, Masayuki Kurosaki, Yukio Osaki, Kouji Joko, Hiroshi Watanabe, Hiroyuki Kimura, Norihiro Nishijima, Atsunori Kusakabe, Namiki Izumi and the Japanese Red Cross Liver Network

    Version of Record online : 20 NOV 2014, DOI: 10.1111/hepr.12427

  11. You have free access to this content
    New therapeutic perspectives in HBV: when to stop NAs

    Liver International

    Volume 34, Issue s1, February 2014, Pages: 146–153, Cristina Pérez-Cameo, Mònica Pons and Rafael Esteban

    Version of Record online : 23 DEC 2013, DOI: 10.1111/liv.12398

  12. You have free access to this content
    HBsAg seroclearance in asymptomatic carriers of high endemic areas: Appreciably high rates during a long-term follow-up

    Hepatology

    Volume 45, Issue 5, May 2007, Pages: 1187–1192, Chia-Ming Chu and Yun-Fan Liaw

    Version of Record online : 26 APR 2007, DOI: 10.1002/hep.21612

  13. Effect of Peg-interferon α-2a combined with Adefovir in HBV postpartum women with normal levels of ALT and high levels of HBV DNA

    Liver International

    Volume 35, Issue 6, June 2015, Pages: 1692–1699, Junfeng Lu, Shibin Zhang, Yali Liu, Xiaofei Du, Shan Ren, Hua Zhang, Lina Ma, Yue Chen, Xinyue Chen and Chengli Shen

    Version of Record online : 21 JAN 2015, DOI: 10.1111/liv.12753

  14. You have free access to this content
    Abstracts 890 to 1096

    Hepatology

    Volume 46, Issue S1, October 2007, Pages: 632A–724A,

    Version of Record online : 19 SEP 2007, DOI: 10.1002/hep.22020

  15. Serial HBV DNA levels in patients with persistently normal transaminase over 10 years following spontaneous HBeAg seroconversion

    Journal of Viral Hepatitis

    Volume 19, Issue 2, February 2012, Pages: 138–146, Y.-C. Chen, S.-F. Huang, C.-M. Chu and Y.-F. Liaw

    Version of Record online : 14 MAR 2011, DOI: 10.1111/j.1365-2893.2011.01450.x

  16. You have free access to this content
    Reduction of hepatitis B surface antigen levels and hepatitis B surface antigen seroclearance in chronic hepatitis B patients receiving 10 years of nucleoside analogue therapy

    Hepatology

    Volume 58, Issue 3, September 2013, Pages: 923–931, Wai-Kay Seto, Danny Ka-Ho Wong, James Fung, Fung-Yu Huang, Ching-Lung Lai and Man-Fung Yuen

    Version of Record online : 24 JUL 2013, DOI: 10.1002/hep.26376

  17. You have free access to this content
    Chronic hepatitis B surface antigen seroclearance-related immune factors

    Hepatology Research

    Volume 47, Issue 1, January 2017, Pages: 49–59, Ting Yuan, Yongfang Jiang, Mei Li and Wei Li

    Version of Record online : 26 MAY 2016, DOI: 10.1111/hepr.12726

  18. Intensification with pegylated interferon during treatment with tenofovir in HIV–hepatitis B virus co-infected patients

    Journal of Viral Hepatitis

    Volume 23, Issue 12, December 2016, Pages: 1017–1026, A. Boyd, L. Piroth, S. Maylin, M. Maynard-Muet, F. Lebossé, C. Bouix, C. Lascoux-Combe, N. Mahjoub, P.-M. Girard, C. Delaugerre, F. Carrat, K. Lacombe and P. Miailhes

    Version of Record online : 3 AUG 2016, DOI: 10.1111/jvh.12581

  19. You have free access to this content
    HBV Natural History and Outcomes

    Hepatology

    Volume 58, Issue S1, October 2013, Pages: 626A–647A,

    Version of Record online : 15 OCT 2013, DOI: 10.1002/hep.26855

  20. Clinical outcomes after spontaneous and nucleos(t)ide analogue-treated HBsAg seroclearance in chronic HBV infection

    Alimentary Pharmacology & Therapeutics

    Volume 43, Issue 12, June 2016, Pages: 1311–1318, Y. C. Chen, W. J. Jeng, R. N. Chien, C. M. Chu and Y. F. Liaw

    Version of Record online : 12 APR 2016, DOI: 10.1111/apt.13630